{"task_id": "e2b8fa5f72655296", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 88/464)", "text": "reatinine suggests CKD),\nChronic Kidney Disease\n73\n\n--- Page 95 ---\nDIAGNOSTIC ISSUES (CONT\u2019D)\nanemia, small kidneys from renal U/S (except dia\nbetes, amyloidosis, acromegaly, renal vein thrombo\nsis, HIV nephropathy), renal osteodystrophy are all\nconsistent with CKD. Renal biopsy is also helpful\nMANAGEMENT\nSLOW PROGRESSION\n\u0002\nLIMIT PROTEIN INTAKE\n0.8 1 g/kg/day\n\u0002 ACE INHIBITION\nblood pressure and proteinuria\ncontrol (ramipril 1.25 10 mg PO daily)\n\u0002\nLIPID CONTROL\n\u0002\nAVOID NEPHROTOXINS\n\u0002\nSMOKING CESSATION\n\u0002\nTREAT DIABETES MELLITUS\nTREAT COMPLICATIONS\n\u0002\nVOLUME OVERLOAD\nlow sodium diet, diuretics\n\u0002\nHYPERKALEMIA (K >5.5 mmol/L)\nlow potassium\ndiet, hydrochlorothiazide 12.5 mg PO daily, kayex\nalate 30 g PO daily QID, decrease ACE inhibitor\n\u0002\nMETABOLIC ACIDOSIS\nconsider NaHCO3 if low pH or\nHCO3\n\u0002\nANEMIA (Hb <100 g/L [Hb <10 g/dL])\nepoetin\nalfa 50 200 U/kg/week SC/IV div 2 3\u0004/week, dar\nbepoetin alfa 0.45 mg/kg SC every week, ferrous\nfumarate 600 mg PO qhs, goal to keep Hb\n100 120 g/L [10 12 g/dL]\n\u0002\nCALCIUM/PHOSPHATE\nBALANCE\nkeep Ca normal,\nPO4 <1.5 mmol/L [<4.6 mg/dL], PTH <2 3\u0004 nor\nmal, dietary phosphate restriction, phosphate bin\nder CaCO3 500 mg PO TID, calcitriol 0.25 1 mg PO\ndaily, parathyroidectomy\nRENAL\nREPLACEMENT\ndialysis\n(peritoneal,\nhemodialysis), renal transplant\nTREATMENT ISSUES\nCRITERIA FOR DIALYSIS IN CHRONIC KIDNEY\nDISEASE\nGFR <10mL/min/1.73m2, CrCl <15mL/\nmin,\nCr\n>1000mmol/L\n[>11.3\nmg/dL],\nurea\n>30 mmol/L [>83 mg/dL], albumin <35 g/L\n[<3.5 g/dL], uremic symptoms, any acute indications\nTREATMENT ISSUES (CONT\u2019D)\nACE INHIBITORS IN RENAL FAILURE\nACE inhibi\ntion leads to vasodilation of efferent arterioles ! #\nintraglomerular pressure ! # long term remodeling/\nstress ! slow progression of chronic kidney disease.\nOther positive effects of ACE inhibition include #\nblood pressure, # proteinuria, and # mediators of\nglomerular tubule hypertrophy and fibrosis. Should\nstart in all patients with chronic kidney disease \u0005\nhypertension \u0005 proteinuria. If <30% rise in creati\nnine after starting ACE inhibitor, should continue as\nlong term benefit important. Expect GFR to return to\npre ACE inhibitor baseline after 3 4 months due to\nremodeling\nSPECIFIC ENTITIES\nDIABETIC NEPHROPATHY\n\u0002\nNORMOALBUMINURIA (<30 mg/day)\nlasts 8 10\nyears, treatment with glycemic/blood pressure/\nlipid control, smoking cessation\n\u0002\nMICROALBUMINURIA (30 300 mg/day)\nlasts 5 10\nyears, same treatment as above plus ACE inhibitor,\nprotein restriction\n\u0002\nOVERT\nNEPHROPATHY\n(>300\nmg/day)\nCrCl\ndeclines by 2 20 mL/min/year, same treatment\nas above\n\u0002\nPERCENTAGES\n25 40% of type 1 or 2 diabetics\ndevelop nephropathy: 99% of type 1 diabetics\nwith chronic kidney disease are related to diabetes,\nwhile this is true only for 30% of type 2 diabetics\nRelated Topics\nAcute Renal Failure (p. 68)\nDiabetes Mellitus (p. 337)\nGlomerulonephritis (p. 70)\nHypertension (p. 57)\nMultiple Myeloma (p. 178)\nPolycystic Kidney Disease (p. 76)\nProteinuria\nDIFFERENTIAL DIAGNOSIS\nFUNCTIONAL (<1 g/day)\ninfection, fever, exer\ncise, orthostatic\nTUBULAR (0.5 1 g/day)\ninterstitial nephritis,\nATN\nGLOMERULAR (1 3 g/day, usually >3 g/day)\nnephrotic syndrome, nephritic syndrome, early\ndiabetes\nOVERFLOW (any amount but usually >1 g/day)\nmultiple myeloma\nPATHOPHYSIOLOGY\nDEFINITION OF PROTEINURIA\n>150 mg/day of\nprotein in urine. Physiologically, <150 mg of protein\nis secreted per day (Tamm Horsfall mucoprotein\nmainly, with <30 mg albumin)\nPROTEIN FILTRATION\nbased on size and charge.\nLarge proteins such as albumin are usually retained\nby glomerular basement membrane (affected in glo\nmerular proteinuria), while small proteins such as b2\nmicroglobulin filter through but are reabsorbed at\nproximal tubules (affected in tubular proteinuria)\n74\nProteinuria", "text_length": 3720, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 88/464)", "type": "chunk", "chunk_index": 87, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.360979", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.361700", "status": "complete", "chunks_added": 2}